Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing Arthroplasty
PharmacoEconomics · 2026-07 · 44 (7) · 839-849
DOI: 10.1007/s40273-026-01609-0 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PharmacoEconomics, online erschienen am 13.03.2026. Verfasst von An Tran-Duy und 15 weiteren Autor:innen. Beteiligte Einrichtung: Health Economics and Simulation Modelling Unit, Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, …. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Antibiotic Prophylaxis, Arthroplasty, Cefazolin. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council, University of Melbourne.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Health Economics and Simulation Modelling Unit, Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia. an.tran@unimelb.edu.au.
- Methods and Implementation Support for Clinical and Health research (MISCH) Hub, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia. an.tran@unimelb.edu.au.
- Department of Infectious Diseases, Bayside Health, Melbourne, VIC, Australia.
- Department of Infectious Diseases, School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
- Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
- Department of Surgery, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia.
Förderung
- National Health and Medical Research Council
- University of Melbourne
Zitieren
APA
Tran-Duy, A., Asbury, S., Spelman, T., Paterson, D. L., Buising, K. L., McDougall, C., Solomon, M., Crawford, R., Adie, S., Molnar, R., Mulford, J., Harris-Brown, T., Roney, J., de Steiger, R., Peel, T. N., & ASAP Trial Group (2026). Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing Arthroplasty. PharmacoEconomics, 44(7), 839-849. https://doi.org/10.1007/s40273-026-01609-0
Vancouver
Tran-Duy A, Asbury S, Spelman T, Paterson DL, Buising KL, McDougall C, et al. Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing Arthroplasty. PharmacoEconomics. 2026;44(7):839-849. doi:10.1007/s40273-026-01609-0
BibTeX
@article{TranDuy2026,
author = {Tran-Duy, An and Asbury, Sarah and Spelman, Tim and Paterson, David L and Buising, Kirsty L and McDougall, Catherine and Solomon, Michael and Crawford, Ross and Adie, Sam and Molnar, Robert and Mulford, Johnthan and Harris-Brown, Tiffany and Roney, Janine and de Steiger, Richard and Peel, Trisha N and ASAP Trial Group, ASAP Trial Group},
title = {Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing Arthroplasty},
journal = {PharmacoEconomics},
year = {2026},
volume = {44},
number = {7},
pages = {839--849},
doi = {10.1007/s40273-026-01609-0}
}
EUVIMED